Supplementary Tables 1-6 from Evaluating Pneumonitis Incidence in Patients with Non–small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data
التفاصيل البيبلوغرافية
العنوان:
Supplementary Tables 1-6 from Evaluating Pneumonitis Incidence in Patients with Non–small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data
American Association for Cancer Research (AACR), 2023.
سنة النشر:
2023
الوصف:
Supplementary Table 1. Pneumonitis defined using A) ICD-9 and B) ICD-10 codes that included ‘pneumonitis’ or associated concepts in the Unified Medical Language System, with Bidirectional General Equivalence Mappings used to identify equivalent terms between ICD-9 and ICD-10 in the Real World Data (RWD) cohortSupplementary Table 2: ICD codes used to identify history of chronic lung condition in the Real World Data (RWD) cohortSupplementary Table 3. Selection of clinical trial (RCT) populationSupplementary Table 4. Incidence of Treatment-Associated Pneumonitis in the Randomized Clinical Trial (RCT) Cohort and the Real World Data (RWD) Cohort based on sensitivity analysesSupplementary Table 5. Treatment-associated pneumonitis counts by grade in the Randomized Clinical Trial (RCT) cohortSupplementary Table 6. Demographic and Clinical Characteristics of Patients With and Without Radiation Therapy (RT) status available in the Real World Data (RWD) Cohort